A new Moffitt Cancer Center study suggests a widely used genomic test can more accurately identify which men with early prostate cancer are at high risk for their disease to come back quickly after ...
Please provide your email address to receive an email when new articles are posted on . Use of a precision navigator led to significant increase in genomic profiling among men with prostate cancer.
We retrospectively reviewed prostate cancer consults within one health care system from November 2, 2021, to January 2, 2023. We compared the proportion of patients who received genomic testing in the ...
Everyday Health on MSN
How to reduce your chance of prostate cancer recurrence
Learn how to reduce your risk of prostate cancer recurrence with healthy habits, diet, exercise, sleep, and regular follow-up ...
A total of 7,201 veterans with metastatic prostate cancer and CGP were identified. There were 2,484 veterans (median [IQR] age, 72 [67-77] years) with synchronous mHSPC and tissue CGP, which were ...
LOS ANGELES--(BUSINESS WIRE)--MiraDx, a molecular diagnostics company focused on genetic testing to personalize cancer treatment, today announced the U.S. commercial launch of PROSTOX™ Standard, a new ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
Everyday Health on MSN
What the Gleason score tells you about your prostate cancer
Learn how Gleason scores and grade groups are calculated, what they mean, and how they guide treatment decisions for prostate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results